A comparative study of regional block (ESP) versus intravenous analgesia undergoing Coronary Artery Bypass Graft Surgeries

A comparative study of Erector Spinae Plane Block versus intravenous analgesia undergoing Beating Heart Coronary Artery Bypass Graft Surgeries: A Prospective Randomized Double Blind Control Study ? - nil

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057221

Enrollment

Registered

2023-09-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I20-I25- Ischemic heart diseases Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Erector Spinae Plane Block: Bilateral erector spinae plane Block with bupivacaine 0.25%, 15 ml total volume was given in the left catheter for 15 min (5 ml each 5 min) followed by the r

Eligibility

Inclusion criteria

Inclusion criteria: 1. American Society of Anesthesiologists physical status classification II–III 2. Elective off-pump cardiac surgery

Exclusion criteria

Exclusion criteria: 1. A patient refused to participate in the study 2. Patient who have cognitive impairment (patients unable to assess verbal numeric pain scales) 3. Patient who undergoing emergency or reoperation, minimally invasive procedures 4. Patient with pre-existing hypersensitivity or allergy to LA, severe dysfunction of a major organ (e.g., renal or hepatic failure), left ventricular ejection fraction less than 30%, mental disorders, pregnant or lactating patients, hematologic disorders, alcohol/drug abuse, and/or daily opioid use.

Design outcomes

Primary

Measure	Time frame
1.To compare the postoperative Visual Analog Scale (VAS) scores of bilateral continuous ESPB with multimodal intravenous analgesia undergoing beating heart coronary by-pass graft (CABG) surgeriesTimepoint: at time of extubating (0hr), 4,8,12 & 48 hours	—

Secondary

Measure	Time frame
1. Intraoperative intravenous analgesic consumtion 2. Hemodynamic response 3. Rescue analgesia 4. ICU stay & perioperative complications Timepoint: at time of extubating (0hr), 4,8,12 & 48 hours.	—

Countries

India

Contacts

Public ContactDr Shashank Dhiraj

Indira Gandhi Institute of Medical Sciences

shashank.dhiraj@gmail.com9546135803

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026